TABLE 2. Linkage to human immunodeficiency virus (HIV) medical care for blacks or African Americans (blacks) with newly diagnosed HIV infection — CDC-funded Phase-I Ending the HIV Epidemic (EHE) jurisdictions,* United States, 2017.
| Characteristic | No. (%) |
||||
|---|---|---|---|---|---|
| CDC-funded tests among blacks in EHE jurisdictions | New diagnoses among blacks in EHE jurisdictions | Linked to HIV medical care within 90 days of diagnoses | Interviewed for partner services | Referred to HIV prevention services | |
|
Age group at test (yrs)†
| |||||
| 13–19 |
59,683 |
183 (0.3) |
117 (84.2) |
88 (71.0) |
122 (84.7) |
| 20–29 |
318,835 |
1,869 (0.6) |
1,257 (81.3) |
1,041 (74.6) |
1,301 (83.2) |
| 30–39 |
193,353 |
1,013 (0.5) |
685 (78.8) |
549 (70.7) |
679 (81.1) |
| 40–49 |
110,772 |
429 (0.4) |
262 (74.4) |
215 (70.0) |
267 (78.1) |
| ≥50 |
158,462 |
501 (0.3) |
301 (74.5) |
225 (62.0) |
322 (80.7) |
|
Gender§
| |||||
| Male |
419,746 |
3,124 (0.7) |
2,039 (79.2) |
1,660 (71.8) |
2,124 (82.4) |
| Female |
420,203 |
785 (0.2) |
517 (78.6) |
407 (69.8) |
499 (79.6) |
|
Test setting
| |||||
| Health care facility |
634,620 |
2,420 (0.4) |
1,644 (80.2) |
1,370 (72.7) |
1,554 (81.7) |
| Non–health care facility |
209,843 |
1,587 (0.8) |
980 (77.6) |
749 (69.2) |
1,139 (82.0) |
|
U.S. Census region¶
| |||||
| Northeast |
115,415 |
586 (0.5) |
447 (86.3) |
384 (83.8) |
473 (83.9) |
| Midwest |
139,838 |
675 (0.5) |
430 (77.0) |
331 (58.9) |
448 (70.2) |
| South |
534,304 |
2,378 (0.4) |
1,539 (79.0) |
1,200 (74.3) |
1,570 (86.6) |
| West |
55,260 |
368 (0.7) |
208 (71.7) |
204 (61.1) |
202 (73.2) |
| U.S. dependent areas |
2 |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
|
Subpopulation in non–health care setting** | |||||
| MSM |
31,508 |
1,030 (3.3) |
664 (80.6) |
484 (71.3) |
763 (84.2) |
| Transgender |
1,964 |
52 (2.6) |
34 (79.1) |
28 (73.7) |
41 (85.4) |
| Persons who inject drugs |
3,139 |
26 (0.8) |
8 (42.1) |
9 (47.4) |
18 (72.0) |
| Heterosexual males |
56,676 |
186 (0.3) |
113 (74.8) |
97 (65.1) |
132 (80.0) |
| Heterosexual females |
64,160 |
189 (0.3) |
114 (75.0) |
92 (74.8) |
125 (77.6) |
| Total | 844,819 | 4,007 (0.5) | 2,624 (79.2) | 2,119 (71.4) | 2,693 (81.8) |
Abbreviation: MSM = gay, bisexual, and other men who have sex with men.
* Fifty local jurisdictions accounting for >50% of new diagnoses during 2016–2017 and seven states with disproportionate occurrence of HIV in rural areas.
† For age, the numbers of records missing or invalid are as follows: in the column “CDC-funded tests among blacks in EHE jurisdictions,” 3,714 (0.4%); in the column “New HIV diagnoses among blacks in EHE jurisdictions,” 12 (0.3%); in the column “Linked to HIV medical care within 90 days of diagnoses,” 2 (0.1%); in the column “Interviewed for partner services,” 1 (0.05%); in the column “Referred to HIV prevention services,” 2 (0.1%).
§ For gender, the numbers of records reported as transgender, missing, or invalid are as follows: in the column “CDC-funded tests among blacks in EHE jurisdictions,” 4870 (0.6%); in the column “New HIV diagnoses among blacks in EHE jurisdictions,” 98 (2.4%); in the column “Linked to HIV medical care within 90 days of diagnoses,” 68 (2.6%); in the column “Interviewed for partner services,” 52 (2.5%); in the column “Referred to HIV prevention services,” 70 (2.6%).
¶ Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia; West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
** MSM include males who reported male-to-male sexual contact as well as males who reported both male-to-male sexual contact and injection drug use in the past 12 months. Persons who inject drugs include persons who reported injection drug use in the past 12 months. Heterosexual males include males who only reported heterosexual contact with a female in the past 12 months. Heterosexual females include females who only reported heterosexual contact with a male in the past 12 months. Data on behavioral risk factors used to define the subpopulation were limited to those tested in non–health care settings. For subpopulation in non–health care settings, the numbers of records missing or invalid are as follows: in the column “CDC-funded tests among blacks in EHE jurisdictions,” 52,396 (25.0%); in the column “New HIV diagnoses among blacks in EHE jurisdictions,” 104 (6.6%); in the column “Linked to HIV medical care within 90 Days of diagnoses,” 47 (4.8%); in the column “Interviewed for partner services,” 39 (5.2%); in the column “Referred to HIV prevention services,” 60 (5.3%). Totals for subpopulation in non–health care settings are 209,843 for CDC-funded tests among blacks in EHE jurisdictions, 1,587 for new diagnoses among blacks in EHE jurisdictions, 980 for linked to HIV medical care within 90 days of diagnoses, 749 for interviewed for partner services, and 1,139 for referred to HIV prevention services.